Law360
Sunshine Overseas: Transparency Rules For Life Sciences
November 2012
In the wake of the U.S. Physician Payments Sunshine Act (signed into law in March 2010), European, Asian and Australian governmental bodies and trade associations have been rapidly adopting “Sunshine-like” transparency and disclosure requirements applicable to life sciences companies.
得意分野
Suggested News & Insights
Sidley Medicaid Drug Rebate Program Summit Cocktail ReceptionMonday, October 5, 2026Sidley Healthcare Investment Conference 2026Tuesday, September 22, 2026Switzerland Expands Integrity Rules to Medical Devices: Key Compliance Implications for Medtech CompaniesAugust 2026Through the Looking Glass: What WHA79 Reveals About the Future of Global Life SciencesAugust 2026Second Circuit Clarifies Scope of “Property” that an FCA “Claim” May SeekAugust 17, 2026Sidley Earns Three Finalist Recognitions in The American Lawyer Industry Awards 2026August 17, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory